ReviewCureus2021

Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors: Delving Into the Potential Benefits of Cardiorenal Protection Beyond the Treatment of Type-2 Diabetes Mellitus.

Natasha Srinivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.